J.Henderson H.BioTech.F.IU2/ LU1897414568 /
| NAV5/26/2023 | Chg.-0.1200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 20.3600USD | -0.59% | reinvestment | Equity Worldwide | Janus Henderson Inv. ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | 16.00 | 5.22 | -0.44 | -3.02 | -4.77 | 5.20 | -2.11 | -1.96 | -4.68 | 7.51 | 11.36 | 4.26 | +34.81% |
| 2020 | -2.73 | -5.61 | -4.54 | 15.46 | 6.58 | 9.29 | 1.70 | 2.27 | 2.62 | 1.08 | 13.68 | 11.04 | +60.55% |
| 2021 | 1.30 | 1.13 | -4.44 | 1.84 | -3.61 | 3.01 | -4.59 | 9.25 | -2.13 | 0.84 | -8.24 | 2.30 | -4.40% |
| 2022 | -18.70 | -1.03 | 0.58 | -9.43 | -5.35 | 2.26 | 5.08 | 6.52 | 3.88 | 8.36 | 4.62 | 3.85 | -2.87% |
| 2023 | 2.10 | -3.06 | 2.01 | 4.58 | 3.72 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 19.98% | 19.78% | 24.26% | 25.10% | -% |
| Sharpe ratio | 1.12 | 1.46 | 2.13 | 0.42 | - |
| Best month | +4.58% | +4.62% | +8.36% | +13.68% | +16.00% |
| Worst month | -3.06% | -3.06% | -5.35% | -18.70% | -18.70% |
| Maximum loss | -8.16% | -8.16% | -9.57% | -45.68% | - |
| Outperformance | +2.27% | - | +19.68% | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| J.Henderson H.BioTech.F.IU2 | reinvestment | 20.3600 | +54.95% | +48.40% | |
| J.Henderson H.BioTech.F.A2 | reinvestment | 20.1000 | +54.14% | +47.90% | |
| J.Henderson H.BioTech.F.H2 | reinvestment | 20.2700 | +54.26% | +47.74% |
Performance
| YTD | +9.52% | ||
|---|---|---|---|
| 6 Months | +14.70% | ||
| 1 Year | +54.95% | ||
| 3 Years | +48.40% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +103.60% | ||
| Year | |||
| 2022 | -2.87% | ||
| 2021 | -4.40% | ||
| 2020 | +60.55% | ||
| 2019 | +34.81% | ||